The US Department of Health and Human Services has launched an initiative, referred to as Operation TrialBlazer, aimed at restoring US leadership in clinical research. The effort is described as a department-wide undertaking, with the goal of reforming access, payment, and infrastructure for clinical trials. Reports suggest that the initiative may include plans to speed up phase 1 clinical trials, with some outlets citing a potential reduction in timelines of 6 to 12 months.